Recombinant GroES in combination with CpG oligodeoxynucleotides protects mice against Mycobacterium avium infection

Journal of Medical Microbiology

Volumn 51, Issue 12, 2002, Pages 1071-1079

  Fattorini, Lanfranco ^a   Creti, Roberta ^a   Nisini, Roberto ^a   Pietrobono, Roberta ^a   Fan, Yuming ^a   Stringaro, Annarita ^a   Arancia, Giuseppe ^a   Serlupi Crescenzi, Ottaviano ^a   Iona, Elisabetta ^a   Orefici, Graziella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYNUCLEOTIDE;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; CELL PROTECTION; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; IMMUNE RESPONSE; IMMUNOELECTRON MICROSCOPY; METHYLATION; MOLECULAR CLONING; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MOTIF; STRAIN DIFFERENCE;

EID: 0036917864     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-12-1071     Document Type: Article

References (35)

1. Inderlied CB, Kemper CA, Bermudez LEM. The Mycobacterium avium complex. Clin Microbiol Rev 1993; 6: 266-310.
2. Horshburg CR. Epidemiology of Mycobacterium avium complex. In: Korvick JA, Benson CA (eds) Mycobacterium Avium Complex Infection: Progress in Research and Treatment. M. Dekker. 1996:1-22.
3. Middleton AM, Chadwick MV, Nicholson AG et al. The role of Mycobacterium avium complex fibronectin attachment protein in adherence to the human respiratory mucosa. Mol Microbiol 2000; 38: 381-391.
4. von Reyn CF, Waddel RD, Eaton T et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire and Kenya. J Clin Microbiol 1993; 31: 3227-3230.
5. Georgopoulos C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 1993; 9: 601-634.
6. Cobb AJ, Frothingham R. The GroES antigens of Mycobacterium avium and Mycobacterium paratuberculosis. Vet Microbiol 1999; 67: 31-35.
7. Verbon A, Kuijper S, Jansen HM, Speelman P, Kolk AH. Antigens in culture supernatant of Mycobacterium tuberculosis: Epitopes defined by monoclonal and human antibodies. J Gen Microbiol 1990; 136: 955-964.
8. Orme IM, Miller ES, Roberts AD et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 1992; 148: 189-196.
9. Coates ARM. Immunological aspects of chaperonins. In: Ellis RJ (ed) The Chaperonins. Academic Press. 1996: 267-296.
10. Gelber RH, Mehra V, Bloom B et al. Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads. Infect Immun 1994; 10: 4250-4255.
11. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995; 92: 6499-6503.
12. Scheule RK. The role of CpG motifs in immunostimulation and gene therapy. Adv Drug Deliv Rev 2000; 44: 119-134.
13. McCluskie MJ, Davis HL. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 2001; 19: 413-422.
14. McCluskie MJ, Davis HL. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol 1998; 161: 4463-4466.
15. Fattorini L, Xiao Y, Ausiello CM et al. Late acquisition of hyporesponsiveness to lipopolysaccharide by Mycobacterium avium-infected human macrophages in producing tumor necrosis factor-alpha but not interleukin-I beta and -6. J Infect Dis 1996; 173: 1030-1034.
16. Ausubel FM, Brent R, Kingston RE et al. Current Protocols in Molecular Biology. New York, John Wiley & Sons. 1995.
17. Mande SC, Mehra V, Bloom BR, Hol WGJ. Structure of the heat shock protein chaperonin-10 of M. leprae. Science 1996; 271: 203-207.
18. Sanger F, Nicklen S. Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
19. Qiagen. The Qiaexpressionist, 3rd Edn. Hilden, Germany, Qiagen. 1997.
20. Wagner B, Fattorini L, Wagner M et al. Antigenic properties and immunoelectron microscopic localization of Mycobacterium fortuitum beta-lactamase. Antimicrob Agents Chemother 1995; 39: 739-745.
21. Molinari A, Calcabrini A, Meschini S et al. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int d Cancer 1998; 75: 885-893.
22. von Hunolstein C, Mariotti S, Teloni R et al. The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines. Vaccine 2001; 19: 3058-3066.
23. Kong TH, Coates ARM, Butcher PD, Hickman CJ, Shinnick TM. M. tuberculosis expresses two chaperonin-60 homologs. Proc Natl Acad Sci USA 1993; 90: 2608-2612.
24. Rinke de Wit TF, Bekelie S, Osland A et al. Mycobacteria contain two groEL genes: The second Mycobacterium leprae groEL gene is arranged in an operon with groES. Mol Microbiol 1992; 6: 1995-2007.
25. Zuber U, Schumann W. CIRCE, a novel heat shock element involved in regulation of heat shock operon dnaK of Bacillus subtilis. J Bacteriol 1994; 176: 1359-1363.
26. Hecker M, Schumann W, Volker U. Heat-shock and general stress response in Bacillus subtilis. Mol Microbiol 1996; 19: 417-428.
27. Schon U, Schumann W. Construction of His6-tagging vectors allowing single-step purification of GroES and other polypeptides produced in Bacillus subtilis. Gene 1994; 147: 91-94.
28. Lewthwaite J, Skinner A, Henderson B. Are molecular chaperones microbial virulence factors? Trenas Microbiol 1998; 6: 426-428.
29. Lowrie DB, Tascon RE, Bonato VL et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400: 269-271.
30. Tighe H, Corr M, Roman R, Raz E. Gene vaccination: Plasmid DNA is more than just a blueprint. Immunol Today 1998; 19: 89-97.
31. Jones TR, Obaldia N, Gramzinski RA et al. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine 1999; 17: 3065-3071.
32. Juffermans NP, Leemans JC, Florquin S et al. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis. Infect Immun 2000; 70: 147-152.
33. Moldoveanu Z, Love-Homan L, Huang WQ, Krieg AM. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 1998; 16: 1216-1224.
34. Freidag BL, Melton GB, Collins F et al. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. Infect Immun 2000; 68: 2948-2953.
35. Kelly BP, Furney SK, Jessen MT, Orme IM. Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis. Antimicrob Agents Chemother 1996; 40: 2809-2812.